HES5 and pulmonary arterial hypertension: The above in vitro and in vivo results suggested that the NOTCH3–HES-5 signaling pathway is constitutively active in the sPASMCs of the media of small precapillary pulmonary arteries in the PAH lung and that high levels of HES-5 protein were associated with the development of medial hyperplasia [8].